25 XP   0   0   10

Vigil Neuroscience Inc
Buy, Hold or Sell?

Let's analyse Vigil Neuroscience Inc together

PenkeI guess you are interested in Vigil Neuroscience Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vigil Neuroscience Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Vigil Neuroscience Inc

I send you an email if I find something interesting about Vigil Neuroscience Inc.

Quick analysis of Vigil Neuroscience Inc (30 sec.)










What can you expect buying and holding a share of Vigil Neuroscience Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$3.50
Expected worth in 1 year
$1.26
How sure are you?
22.2%

+ What do you gain per year?

Total Gains per Share
$-2.24
Return On Investment
-70.0%

For what price can you sell your share?

Current Price per Share
$3.20
Expected price per share
$2.27 - $3.68
How sure are you?
50%

1. Valuation of Vigil Neuroscience Inc (5 min.)




Live pricePrice per Share (EOD)

$3.20

2. Growth of Vigil Neuroscience Inc (5 min.)




Is Vigil Neuroscience Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$135.8m$113.3m$49.2m30.3%

How much money is Vigil Neuroscience Inc making?

Current yearPrevious yearGrowGrow %
Making money-$11.2m-$15.6m$4.3m39.0%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Vigil Neuroscience Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#331 / 1031

Most Revenue
#807 / 1031

Most Profit
#608 / 1031

Most Efficient
#250 / 1031

What can you expect buying and holding a share of Vigil Neuroscience Inc? (5 min.)

Welcome investor! Vigil Neuroscience Inc's management wants to use your money to grow the business. In return you get a share of Vigil Neuroscience Inc.

What can you expect buying and holding a share of Vigil Neuroscience Inc?

First you should know what it really means to hold a share of Vigil Neuroscience Inc. And how you can make/lose money.

Speculation

The Price per Share of Vigil Neuroscience Inc is $3.2. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vigil Neuroscience Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vigil Neuroscience Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $3.50. Based on the TTM, the Book Value Change Per Share is $-0.56 per quarter. Based on the YOY, the Book Value Change Per Share is $1.83 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vigil Neuroscience Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.53-16.5%-0.51-16.0%-0.44-13.7%-0.45-14.2%-0.45-14.2%
Usd Book Value Change Per Share-0.48-15.0%-0.56-17.5%1.8357.3%0.3912.2%0.3912.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.48-15.0%-0.56-17.5%1.8357.3%0.3912.2%0.3912.2%
Usd Price Per Share5.39-9.27-4.68-6.20-6.20-
Price to Earnings Ratio-2.55--4.58--2.53--3.16--3.16-
Price-to-Total Gains Ratio-11.24--16.87-0.34--9.49--9.49-
Price to Book Ratio1.54-2.16-0.93-1.37-1.37-
Price-to-Total Gains Ratio-11.24--16.87-0.34--9.49--9.49-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.2
Number of shares312
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.560.39
Usd Total Gains Per Share-0.560.39
Gains per Quarter (312 shares)-174.66121.34
Gains per Year (312 shares)-698.64485.35
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-699-7090485475
20-1397-14080971960
30-2096-2107014561445
40-2795-2806019411930
50-3493-3505024272415
60-4192-4204029122900
70-4890-4903033973385
80-5589-5602038833870
90-6288-6301043684355
100-6986-7000048534840

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.09.00.00.0%0.09.00.00.0%0.09.00.00.0%0.09.00.00.0%
Book Value Change Per Share0.04.00.00.0%2.07.00.022.2%2.07.00.022.2%2.07.00.022.2%2.07.00.022.2%
Dividend per Share0.00.04.00.0%0.00.09.00.0%0.00.09.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share0.04.00.00.0%2.07.00.022.2%2.07.00.022.2%2.07.00.022.2%2.07.00.022.2%

Fundamentals of Vigil Neuroscience Inc

About Vigil Neuroscience Inc

Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101, a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 proof-of-concept trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also conducting IND-enabling studies with a novel small molecule TREM2 agonist program to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Watertown, Massachusetts.

Fundamental data was last updated by Penke on 2024-03-19 05:03:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Vigil Neuroscience Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vigil Neuroscience Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vigil Neuroscience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--171.8%+171.8%
TTM--205.8%+205.8%
YOY--262.1%+262.1%
5Y--455.6%+455.6%
10Y--589.0%+589.0%
1.1.2. Return on Assets

Shows how efficient Vigil Neuroscience Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • -12.9% Return on Assets means that Vigil Neuroscience Inc generated $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vigil Neuroscience Inc:

  • The MRQ is -12.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.9%TTM-6.7%-6.1%
TTM-6.7%YOY-10.1%+3.3%
TTM-6.7%5Y-8.5%+1.8%
5Y-8.5%10Y-8.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.9%-12.5%-0.4%
TTM-6.7%-12.2%+5.5%
YOY-10.1%-11.2%+1.1%
5Y-8.5%-13.4%+4.9%
10Y-8.5%-14.7%+6.2%
1.1.3. Return on Equity

Shows how efficient Vigil Neuroscience Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • -15.1% Return on Equity means Vigil Neuroscience Inc generated $-0.15 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vigil Neuroscience Inc:

  • The MRQ is -15.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.1%TTM-7.9%-7.2%
TTM-7.9%YOY-7.2%-0.7%
TTM-7.9%5Y-6.7%-1.2%
5Y-6.7%10Y-6.7%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.1%-15.8%+0.7%
TTM-7.9%-15.7%+7.8%
YOY-7.2%-13.9%+6.7%
5Y-6.7%-18.3%+11.6%
10Y-6.7%-19.2%+12.5%

1.2. Operating Efficiency of Vigil Neuroscience Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vigil Neuroscience Inc is operating .

  • Measures how much profit Vigil Neuroscience Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vigil Neuroscience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM--210.1%+210.1%
YOY--279.7%+279.7%
5Y--459.9%+459.9%
10Y--596.9%+596.9%
1.2.2. Operating Ratio

Measures how efficient Vigil Neuroscience Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vigil Neuroscience Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.861-2.861
TTM-3.193-3.193
YOY-3.615-3.615
5Y-5.560-5.560
10Y-7.396-7.396

1.3. Liquidity of Vigil Neuroscience Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vigil Neuroscience Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 13.79 means the company has $13.79 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vigil Neuroscience Inc:

  • The MRQ is 13.789. The company is very able to pay all its short-term debts. +2
  • The TTM is 18.411. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ13.789TTM18.411-4.622
TTM18.411YOY19.808-1.397
TTM18.4115Y18.281+0.130
5Y18.28110Y18.2810.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ13.7893.986+9.803
TTM18.4114.440+13.971
YOY19.8085.552+14.256
5Y18.2816.158+12.123
10Y18.2816.492+11.789
1.3.2. Quick Ratio

Measures if Vigil Neuroscience Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • A Quick Ratio of 23.85 means the company can pay off $23.85 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vigil Neuroscience Inc:

  • The MRQ is 23.855. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 25.376. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ23.855TTM25.376-1.521
TTM25.376YOY18.915+6.461
TTM25.3765Y20.965+4.410
5Y20.96510Y20.9650.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ23.8553.638+20.217
TTM25.3764.168+21.208
YOY18.9155.515+13.400
5Y20.9656.012+14.953
10Y20.9656.209+14.756

1.4. Solvency of Vigil Neuroscience Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vigil Neuroscience Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vigil Neuroscience Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.15 means that Vigil Neuroscience Inc assets are financed with 14.7% credit (debt) and the remaining percentage (100% - 14.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vigil Neuroscience Inc:

  • The MRQ is 0.147. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.109. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.147TTM0.109+0.038
TTM0.109YOY0.452-0.343
TTM0.1095Y0.416-0.307
5Y0.41610Y0.4160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1470.335-0.188
TTM0.1090.330-0.221
YOY0.4520.267+0.185
5Y0.4160.367+0.049
10Y0.4160.378+0.038
1.4.2. Debt to Equity Ratio

Measures if Vigil Neuroscience Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 17.2% means that company has $0.17 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vigil Neuroscience Inc:

  • The MRQ is 0.172. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.124. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.172TTM0.124+0.048
TTM0.124YOY0.034+0.090
TTM0.1245Y0.070+0.054
5Y0.07010Y0.0700.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1720.376-0.204
TTM0.1240.398-0.274
YOY0.0340.334-0.300
5Y0.0700.429-0.359
10Y0.0700.476-0.406

2. Market Valuation of Vigil Neuroscience Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vigil Neuroscience Inc generates.

  • Above 15 is considered overpriced but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • A PE ratio of -2.55 means the investor is paying $-2.55 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vigil Neuroscience Inc:

  • The EOD is -1.515. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.552. Based on the earnings, the company is expensive. -2
  • The TTM is -4.584. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.515MRQ-2.552+1.037
MRQ-2.552TTM-4.584+2.032
TTM-4.584YOY-2.534-2.050
TTM-4.5845Y-3.164-1.420
5Y-3.16410Y-3.1640.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.515-2.643+1.128
MRQ-2.552-2.418-0.134
TTM-4.584-2.742-1.842
YOY-2.534-4.123+1.589
5Y-3.164-6.257+3.093
10Y-3.164-6.478+3.314
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vigil Neuroscience Inc:

  • The EOD is -1.788. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.012. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -4.992. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.788MRQ-3.012+1.224
MRQ-3.012TTM-4.992+1.980
TTM-4.992YOY-2.522-2.471
TTM-4.9925Y-3.340-1.653
5Y-3.34010Y-3.3400.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.788-3.244+1.456
MRQ-3.012-2.939-0.073
TTM-4.992-3.478-1.514
YOY-2.522-5.592+3.070
5Y-3.340-8.473+5.133
10Y-3.340-8.881+5.541
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vigil Neuroscience Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.54 means the investor is paying $1.54 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vigil Neuroscience Inc:

  • The EOD is 0.914. Based on the equity, the company is cheap. +2
  • The MRQ is 1.540. Based on the equity, the company is underpriced. +1
  • The TTM is 2.162. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.914MRQ1.540-0.626
MRQ1.540TTM2.162-0.622
TTM2.162YOY0.929+1.233
TTM2.1625Y1.374+0.788
5Y1.37410Y1.3740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.9142.124-1.210
MRQ1.5402.041-0.501
TTM2.1622.118+0.044
YOY0.9292.915-1.986
5Y1.3743.682-2.308
10Y1.3744.114-2.740
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vigil Neuroscience Inc.

3.1. Institutions holding Vigil Neuroscience Inc

Institutions are holding 88.048% of the shares of Vigil Neuroscience Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Northpond Ventures, LLC11.746967.7766421449800
2023-09-30Citadel Advisors Llc6.03750.00252166113-14211-0.6518
2023-09-30Deerfield Management Co5.09350.2171827400-224610-10.9459
2023-09-30Bvf Inc5.05510.2636181363300
2023-12-31Artal Group S A5.04830.20351811191-96944-5.0806
2023-12-31Deep Track Capital, LP4.44550.181594931-172200-9.7446
2023-12-31BlackRock Inc2.56190.0001919132718538.4804
2023-12-31Vanguard Group Inc2.22760.000179919752310.6588
2023-12-31Pivotal bioVenture Partners Investment Advisor LLC1.56250.480756059500
2023-12-31Sphera Funds Management Ltd.1.49150.29115351205351200
2023-12-31Rock Springs Capital Management LP1.31550.039347195800
2023-12-31Orbimed Advisors, LLC1.25120.030344889100
2023-12-31Geode Capital Management, LLC0.87950.0001315538103633.3958
2023-12-31ArrowMark Colorado Holdings, LLC (ArrowMark Partners)0.80680.01082894602894600
2023-12-31State Street Corporation0.78960.000128329156782.0453
2023-12-31Ensign Peak Advisors Inc0.63740.00152286742167501817.7625
2023-12-31Anson Funds Management LP0.5770.08652070162070160
2023-12-31Trustees Of Columbia University In The City Of New York0.53791.376519297300
2023-12-31Goldman Sachs Group Inc0.47440.00011702002399816.4143
2023-12-31Northern Trust Corp0.39410.00011414011566712.4604
Total 52.933770.960518991212+873171+4.6%

3.2. Funds holding Vigil Neuroscience Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.72850.00016201408840016.6247
2024-02-29iShares Russell 2000 ETF1.03430.0021371072-61-0.0164
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.47450.000617023800
2023-12-31Fidelity Small Cap Index0.42120.00215110838772.6333
2024-01-31Fidelity Select Biotechnology0.39110.008314032500
2024-02-01iShares Russell 2000 Value ETF0.3870.00321388351760.1269
2023-12-31Bridgeway Ultra-Small Company Market0.34860.22751250641200002369.6682
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.2810.000810080000
2024-01-31Fidelity Extended Market Index0.20350.00067301357758.5889
2024-02-29State St Russell Sm Cap® Indx SL Cl I0.16330.00225860000
2024-02-29Vanguard Russell 2000 ETF0.16140.00215790046288.6875
2023-12-31NT R2000 Value Index Fund - NL0.11830.003842426-6831-13.8681
2023-12-31NT R2000 Index Fund - NL0.11740.00242125-6718-13.7543
2024-01-31Schwab Small Cap Index0.10240.00183673300
2024-02-29iShares Micro-Cap ETF0.09730.01333492300
2023-12-31NT R2000 Index Fund - DC - NL - 20.09250.00233174-5439-14.0859
2023-12-31Northern Trust Russell 2000 Value Index0.08540.0043064600
2023-12-31NT R2000 Value Index Fund - L0.08540.0043064600
2024-01-31Fidelity Total Market Index0.0780.00012799000
2024-01-31iShares Russell 2000 Small-Cap Idx Instl0.07110.00162549700
Total 6.44220.28212311255+203807+8.8%

3.3. Insider Transactions

Insiders are holding 9.596% of the shares of Vigil Neuroscience Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-20Ivana Magovcevic-liebischBUY40003.75

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Vigil Neuroscience Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.479-0.560+17%1.834-126%0.389-223%0.389-223%
Book Value Per Share--3.5004.210-17%3.158+11%3.097+13%3.097+13%
Current Ratio--13.78918.411-25%19.808-30%18.281-25%18.281-25%
Debt To Asset Ratio--0.1470.109+35%0.452-68%0.416-65%0.416-65%
Debt To Equity Ratio--0.1720.124+39%0.034+409%0.070+145%0.070+145%
Dividend Per Share----0%-0%-0%-0%
Eps---0.528-0.511-3%-0.438-17%-0.455-14%-0.455-14%
Free Cash Flow Per Share---0.447-0.472+5%-0.460+3%-0.449+0%-0.449+0%
Free Cash Flow To Equity Per Share---0.446-0.466+4%0.649-169%0.325-237%0.325-237%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap114807680.000-82%209181097.510357728557.998-42%167816538.500+25%233575598.443-10%233575598.443-10%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio0.914-68%1.5402.162-29%0.929+66%1.374+12%1.374+12%
Pe Ratio-1.515+41%-2.552-4.584+80%-2.534-1%-3.164+24%-3.164+24%
Price Per Share3.200-68%5.3909.270-42%4.678+15%6.199-13%6.199-13%
Price To Free Cash Flow Ratio-1.788+41%-3.012-4.992+66%-2.522-16%-3.340+11%-3.340+11%
Price To Total Gains Ratio-6.675+41%-11.244-16.865+50%0.341-3394%-9.491-16%-9.491-16%
Quick Ratio--23.85525.376-6%18.915+26%20.965+14%20.965+14%
Return On Assets---0.129-0.067-48%-0.101-22%-0.085-34%-0.085-34%
Return On Equity---0.151-0.079-48%-0.072-52%-0.067-55%-0.067-55%
Total Gains Per Share---0.479-0.560+17%1.834-126%0.389-223%0.389-223%
Usd Book Value--135836000.000162523250.000-16%113318250.000+20%116234222.222+17%116234222.222+17%
Usd Book Value Change Per Share---0.479-0.560+17%1.834-126%0.389-223%0.389-223%
Usd Book Value Per Share--3.5004.210-17%3.158+11%3.097+13%3.097+13%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.528-0.511-3%-0.438-17%-0.455-14%-0.455-14%
Usd Free Cash Flow---17361000.000-18218250.000+5%-16521250.000-5%-16682000.000-4%-16682000.000-4%
Usd Free Cash Flow Per Share---0.447-0.472+5%-0.460+3%-0.449+0%-0.449+0%
Usd Free Cash Flow To Equity Per Share---0.446-0.466+4%0.649-169%0.325-237%0.325-237%
Usd Market Cap114807680.000-82%209181097.510357728557.998-42%167816538.500+25%233575598.443-10%233575598.443-10%
Usd Price Per Share3.200-68%5.3909.270-42%4.678+15%6.199-13%6.199-13%
Usd Profit---20495000.000-11271000.000-45%-15668000.000-24%-13166222.222-36%-13166222.222-36%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.479-0.560+17%1.834-126%0.389-223%0.389-223%
 EOD+3 -5MRQTTM+12 -17YOY+12 -175Y+8 -2110Y+8 -21

4.2. Fundamental Score

Let's check the fundamental score of Vigil Neuroscience Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.515
Price to Book Ratio (EOD)Between0-10.914
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than123.855
Current Ratio (MRQ)Greater than113.789
Debt to Asset Ratio (MRQ)Less than10.147
Debt to Equity Ratio (MRQ)Less than10.172
Return on Equity (MRQ)Greater than0.15-0.151
Return on Assets (MRQ)Greater than0.05-0.129
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Vigil Neuroscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.116
Ma 20Greater thanMa 503.122
Ma 50Greater thanMa 1003.064
Ma 100Greater thanMa 2003.572
OpenGreater thanClose2.850
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets159,156
Total Liabilities23,320
Total Stockholder Equity135,836
 As reported
Total Liabilities 23,320
Total Stockholder Equity+ 135,836
Total Assets = 159,156

Assets

Total Assets159,156
Total Current Assets139,847
Long-term Assets19,309
Total Current Assets
Cash And Cash Equivalents 56,794
Short-term Investments 76,849
Net Receivables 604
Other Current Assets 1,123
Total Current Assets  (as reported)139,847
Total Current Assets  (calculated)135,370
+/- 4,477
Long-term Assets
Property Plant Equipment 18,382
Long-term Assets Other 927
Long-term Assets  (as reported)19,309
Long-term Assets  (calculated)19,309
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,142
Long-term Liabilities13,178
Total Stockholder Equity135,836
Total Current Liabilities
Short-term Debt 874
Accounts payable 1,302
Other Current Liabilities 98
Total Current Liabilities  (as reported)10,142
Total Current Liabilities  (calculated)2,274
+/- 7,868
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt13,178
Long-term Liabilities  (as reported)13,178
Long-term Liabilities  (calculated)13,178
+/-0
Total Stockholder Equity
Common Stock4
Retained Earnings -200,598
Accumulated Other Comprehensive Income -56
Other Stockholders Equity 336,486
Total Stockholder Equity (as reported)135,836
Total Stockholder Equity (calculated)135,836
+/-0
Other
Capital Stock4
Cash and Short Term Investments 164,480
Common Stock Shares Outstanding 38,809
Current Deferred Revenue7,868
Liabilities and Stockholders Equity 159,156
Net Debt -42,742
Net Invested Capital 135,836
Net Working Capital 129,705
Property Plant and Equipment Gross 18,382
Short Long Term Debt Total 14,052



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
0
0
0
0
114,415
102,441
172,812
157,928
215,509
200,393
192,361
175,409
159,156
159,156175,409192,361200,393215,509157,928172,812102,441114,4150000
   > Total Current Assets 
0
0
33,538
33,538
111,906
97,483
170,425
155,741
212,938
197,805
172,216
155,719
139,847
139,847155,719172,216197,805212,938155,741170,42597,483111,90633,53833,53800
       Cash And Cash Equivalents 
0
0
0
0
110,656
91,420
163,324
148,912
203,863
186,605
95,618
58,741
56,794
56,79458,74195,618186,605203,863148,912163,32491,420110,6560000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
68,862
91,423
76,849
76,84991,42368,8620000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
604
604000000000000
       Other Current Assets 
0
0
53
53
225
466
468
1,221
702
628
1,359
1,178
1,123
1,1231,1781,3596287021,221468466225535300
   > Long-term Assets 
0
0
0
0
2,509
4,958
2,387
2,187
2,571
2,588
20,145
19,690
19,309
19,30919,69020,1452,5882,5712,1872,3874,9582,5090000
       Property Plant Equipment 
0
0
635
635
655
1,274
1,344
1,231
1,451
1,395
19,218
18,763
18,382
18,38218,76319,2181,3951,4511,2311,3441,27465563563500
       Other Assets 
0
0
37
37
1,854
3,684
1,043
956
1,120
1,193
0
927
0
092701,1931,1209561,0433,6841,854373700
> Total Liabilities 
0
0
0
0
171,673
171,884
6,634
7,302
9,597
11,312
21,021
21,573
23,320
23,32021,57321,02111,3129,5977,3026,634171,884171,6730000
   > Total Current Liabilities 
0
0
8,773
8,773
9,601
9,881
6,599
7,294
9,597
11,312
7,391
8,167
10,142
10,1428,1677,39111,3129,5977,2946,5999,8819,6018,7738,77300
       Short-term Debt 
0
0
0
0
360
873
734
541
381
176
1,060
804
874
8748041,0601763815417348733600000
       Accounts payable 
0
0
4,273
4,273
5,104
3,977
2,713
1,732
2,363
1,942
2,166
2,362
1,302
1,3022,3622,1661,9422,3631,7322,7133,9775,1044,2734,27300
       Other Current Liabilities 
0
0
148
148
63
116
3,152
5,021
6,853
9,194
4,165
217
98
982174,1659,1946,8535,0213,1521166314814800
   > Long-term Liabilities 
0
0
0
0
162,072
162,003
35
8
2,744
2,118
13,630
13,406
13,178
13,17813,40613,6302,1182,744835162,003162,0720000
       Deferred Long Term Liability 
0
0
0
0
911
2,757
116
29
193
0
0
0
0
0000193291162,7579110000
> Total Stockholder Equity
0
0
0
0
-57,258
-69,443
166,178
150,626
205,912
189,081
171,340
153,836
135,836
135,836153,836171,340189,081205,912150,626166,178-69,443-57,2580000
   Common Stock
0
0
1
1
1
0
3
3
4
4
4
4
4
4444433011100
   Retained Earnings Total Equity00-159,929-140,134-121,678-104,1780000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
-172,812
0
0
0
106
-70
-56
-56-70106000-172,812000000
   Capital Surplus 
0
0
0
0
0
0
0
254,801
327,586
329,211
331,159
0
0
00331,159329,211327,586254,8010000000
   Treasury Stock0000000000000
   Other Stockholders Equity 
0
0
0
0
1,586
2,386
253,338
96,873
112,077
329,211
331,159
334,005
336,486
336,486334,005331,159329,211112,07796,873253,3382,3861,5860000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue--
Gross Profit-0
 
Operating Income (+$)
Gross Profit-
Operating Expense-83,882
Operating Income-83,882-83,882
 
Operating Expense (+$)
Research Development56,343
Selling General Administrative27,539
Selling And Marketing Expenses-
Operating Expense83,88283,882
 
Net Interest Income (+$)
Interest Income4,986
Interest Expense--
Other Finance Cost-0
Net Interest Income4,986
 
Pretax Income (+$)
Operating Income-83,882
Net Interest Income4,986
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-78,920-83,858
EBIT - interestExpense = 0
-78,920
-78,920
Interest Expense-
Earnings Before Interest and Taxes (EBIT)--78,920
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-78,920
Tax Provision--
Net Income From Continuing Ops-78,920-78,920
Net Income-78,920
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-24-4,986
 

Technical Analysis of Vigil Neuroscience Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vigil Neuroscience Inc. The general trend of Vigil Neuroscience Inc is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vigil Neuroscience Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vigil Neuroscience Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 3.54 < 3.62 < 3.68.

The bearish price targets are: 2.7 > 2.53 > 2.27.

Tweet this
Vigil Neuroscience Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vigil Neuroscience Inc. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vigil Neuroscience Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vigil Neuroscience Inc. The current macd is -0.04622493.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vigil Neuroscience Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Vigil Neuroscience Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Vigil Neuroscience Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vigil Neuroscience Inc Daily Moving Average Convergence/Divergence (MACD) ChartVigil Neuroscience Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vigil Neuroscience Inc. The current adx is 12.33.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Vigil Neuroscience Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Vigil Neuroscience Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vigil Neuroscience Inc. The current sar is 3.49177744.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Vigil Neuroscience Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vigil Neuroscience Inc. The current rsi is 52.12. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Vigil Neuroscience Inc Daily Relative Strength Index (RSI) ChartVigil Neuroscience Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vigil Neuroscience Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Vigil Neuroscience Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Vigil Neuroscience Inc Daily Stochastic Oscillator ChartVigil Neuroscience Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vigil Neuroscience Inc. The current cci is -33.24670596.

Vigil Neuroscience Inc Daily Commodity Channel Index (CCI) ChartVigil Neuroscience Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vigil Neuroscience Inc. The current cmo is 7.90101439.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Vigil Neuroscience Inc Daily Chande Momentum Oscillator (CMO) ChartVigil Neuroscience Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vigil Neuroscience Inc. The current willr is -40.47619048.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vigil Neuroscience Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vigil Neuroscience Inc Daily Williams %R ChartVigil Neuroscience Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vigil Neuroscience Inc.

Vigil Neuroscience Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vigil Neuroscience Inc. The current atr is 0.32519728.

Vigil Neuroscience Inc Daily Average True Range (ATR) ChartVigil Neuroscience Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vigil Neuroscience Inc. The current obv is -3,752,735.

Vigil Neuroscience Inc Daily On-Balance Volume (OBV) ChartVigil Neuroscience Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vigil Neuroscience Inc. The current mfi is 35.28.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Vigil Neuroscience Inc Daily Money Flow Index (MFI) ChartVigil Neuroscience Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vigil Neuroscience Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-25SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Vigil Neuroscience Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vigil Neuroscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.116
Ma 20Greater thanMa 503.122
Ma 50Greater thanMa 1003.064
Ma 100Greater thanMa 2003.572
OpenGreater thanClose2.850
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vigil Neuroscience Inc with someone you think should read this too:
  • Are you bullish or bearish on Vigil Neuroscience Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vigil Neuroscience Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vigil Neuroscience Inc

I send you an email if I find something interesting about Vigil Neuroscience Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Vigil Neuroscience Inc.

Receive notifications about Vigil Neuroscience Inc in your mailbox!